China NMPA Product Recall - Medtronic PRO+ Transcatheter Aortic Valve System

Medtronic Inc. initiated a voluntary Class III recall of its Transcatheter Aortic Valve System, specifically the Medtronic PRO+ System (National Medical Device Registration Certificate No. 20243130221). The recall was publicly reported by Medtronic (Shanghai) Management Co., Ltd. on December 23, 2024, in coordination with the National Medical Products Administration (NMPA) of China. The reason for this action stems from identified regulatory compliance issues encountered in Thailand. It is important to note that the specific products implicated in this recall were not distributed or imported into China, as confirmed by Medtronic. The recall details, including specific models, specifications, and batch numbers, are documented in an accompanying 'Medical Device Notification Form' and 'Medical Device Recall Event Report Form'. This proactive measure aligns with global regulatory standards for medical device oversight, even though the affected products did not reach the Chinese market, highlighting the international scope of medical device regulatory reporting and manufacturer responsibility.